Home » Topics » BioWorld Science

BioWorld Science
RSS

Monoclonal antibodies in AR-701 cocktail neutralize SARS-CoV-2 Omicron variant

Feb. 18, 2022

Neumora licenses rights to novel M4 receptor PAMs from Vanderbilt for schizophrenia

Feb. 18, 2022

CECR2 promotes breast cancer metastasis through NF-kappaB signaling and immunosuppression

Feb. 18, 2022

Extracellular domains are not effective targets to disrupt intracellular HER2-HER3 tumor signaling

Feb. 18, 2022

CROI 2022: Predicting the future to get ahead of viruses

Feb. 17, 2022

BetterLife reports findings from preclinical neural plasticity study of BETR-001

Feb. 17, 2022

Intellia and ONK enter licensing and collaboration agreement for allogeneic NK cell therapies

Feb. 17, 2022

Insilico Medicine nominates preclinical compound in QPCTL program

Feb. 17, 2022

FDA grants orphan drug designation to HSB-1216 for uveal melanoma

Feb. 17, 2022

Asep advances antibiofilm peptide technology for wound dressings

Feb. 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...